Malignancy in hepato-biliary-pancreatic field
Conditions
Interventions
None listed
Sponsors
Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University
Kansai Hepato-Biliary Oncology Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who underwent test for microsatellite instability between 2019 and 2022
Exclusion criteria
Exclusion criteria: Patients who do not agree for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of high microsatellite instability in malignancy in hepato-biliary-pancreatic field | — |
Secondary
| Measure | Time frame |
|---|---|
| characteristic of patients with malignancy with high microsatellite instability | — |
Countries
Japan
Contacts
Public ContactShoji Kubo
Osaka City University Department of Hepato-Biliary-Pancreatic Surgery
Outcome results
None listed